logo

For the Inventor, By the Inventor

Hitchin, United Kingdom

Michael Alistair O'Brien

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 8.7

ph-index = 11

Forward Citations = 284(Granted Patents)


Location History:

  • Herts, GB (2008 - 2013)
  • Hitchin, GB (2010 - 2014)
  • Hertz, GB (2012 - 2018)
  • Welwyn Garden, GB (2017 - 2018)
  • Welwyn Garden City, GB (2017 - 2019)
  • Cambridge, GB (2011 - 2021)

Company Filing History:

goldMedal15 out of 123 
 
Astex Therapeutics Limited
 patents
silverMedal8 out of 85 
 
Heptares Therapeutics Limited
 patents
bronzeMedal1 out of 51 
 
The Institute of Cancer Research: Royal Cancer Hospital
 patents
4. 1 out of 263 
 
Cancer Research Technology Limited
 patents
where one patent can have more than one assignee

Years Active: 2008-2021

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents
1. 10961225 - Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor (2021-03-30),
2. 10689368 - Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor (2020-06-23),
3. 10385039 - Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists (2019-08-20),
4. 10196380 - Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists (2019-02-05),
5. 10030012 - Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists (2018-07-24),
6. 9926297 - Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists (2018-03-27),
7. 9914719 - Hydroxybenzamide derivatives and their use as inhibitors of HSP90 (2018-03-13),
8. 9670183 - Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists (2017-06-06),
9. 9593106 - Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists (2017-03-14),
10. 9051278 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators (2015-06-09),
11. 8895745 - Bicyclic heterocyclic compounds as FGFR inhibitors (2014-11-25),
12. 8779147 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators (2014-07-15),
13. 8779132 - Pharmaceutical compounds (2014-07-15),
14. 8530469 - Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 (2013-09-10),
15. 8513276 - Imidazo[1,2-a]pyridine compounds for use in treating cancer (2013-08-20),

Title: Michael Alistair O'Brien - Pioneering Inventor from Hitchin, GB

Introduction: Michael Alistair O'Brien is a distinguished inventor hailing from Hitchin, GB, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Michael Alistair O'Brien holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With over two decades of experience in the industry, Michael Alistair O'Brien has worked with leading tech companies to develop cutting-edge solutions that have revolutionized various sectors.

Collaborations: Throughout his career, Michael Alistair O'Brien has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Michael Alistair O'Brien's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…